Semi-Annual Statement Of Cash Flows

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7586092

Concept As at
2022-09-30
2022-04-01 to
2022-09-30
As at
2022-03-31
As at
2021-09-30
2021-04-01 to
2021-09-30
As at
2021-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
1,907,000,000 JPY
2,203,000,000 JPY
Interest and dividends received
184,000,000 JPY
137,000,000 JPY
Interest paid
-26,000,000 JPY
-30,000,000 JPY
Income taxes paid
-398,000,000 JPY
-894,000,000 JPY
Net cash provided by (used in) operating activities
1,666,000,000 JPY
1,417,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-292,000,000 JPY
-262,000,000 JPY
Proceeds from sale of investment securities
56,000,000 JPY
JPY
Other, net
58,000,000 JPY
22,000,000 JPY
Net cash provided by (used in) investing activities
-199,000,000 JPY
-427,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-1,149,000,000 JPY
-1,149,000,000 JPY
Dividends paid
-225,000,000 JPY
-199,000,000 JPY
Net cash provided by (used in) financing activities
-1,346,000,000 JPY
-1,386,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
0 JPY
0 JPY
Net increase (decrease) in cash and cash equivalents
121,000,000 JPY
-396,000,000 JPY
Cash and cash equivalents
17,224,000,000 JPY
17,103,000,000 JPY
10,117,000,000 JPY
10,514,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.